Pfizer Receives Expanded FDA Approval for RSV Vaccine - The Wall Street Journal

Pfizer Receives Expanded FDA Approval for RSV Vaccine  The Wall Street JournalUS FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease  ReutersWith expanded FDA nod for RSV shot Abrysvo, Pfizer gains edge on GSK's Arexvy. But will it amount to much?  FiercePharmaGSK's Arexvy Vaccine Shows Strong Efficacy Against RSV in Older Adults  AJMC.com Managed Markets NetworkHealthCentral: Which RSV Vaccine Is Right for You?  Cedars-